These results are consistent with previous structural studies of a unique melanoma neoepitope arising from a threonine-to-isoleucine mutation in a peptide derived from triose phosphate isomerase that produced only subtle changes in the binding surface for TCR15,16. Here, TPI1 is linked to melanoma.